首页/数据集/Dataset from A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes

Dataset from A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes

NIAID Data Ecosystem2026-05-10 收录

2型糖尿病药物临床试验

糖尿病药物疗效与安全性比较

数据链接：

https://doi.org/10.25934/00002509 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to determine the safety and effectiveness of adding alogliptin, once daily (QD), compared to glipizide with metformin in diabetic patients.

应用场景：

创建时间：

2025-12-08

2型糖尿病药物临床试验

SGLT2抑制剂药理学

Introduction This randomized, double-blind, placebo-controlled, single and multiple ascending-dose study evaluated the pharmacodynamic effects and safety/tolerability of canagliflozin, a sodium glucos

NIAID Data Ecosystem50

Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

2型糖尿病药物临床试验

心血管风险评估

The purpose of the trial is to assess the efficacy and safety of tirzepatide taken once a week to insulin glargine taken once daily in participants with type 2 diabetes and increased cardiovascular

DataCite Commons2025-07-02 更新00

Available IPD datapackage for study 'A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin'

2型糖尿病药物临床试验

胰高血糖素样肽-1受体激动剂疗效评估

The purpose of this study is to evaluate the benefits and risks of lixisenatide (AVE0010), in comparison to placebo, as an add-on treatment to metformin, over a period of 24 weeks of treatment, foll

DataCite Commons2024-12-02 更新00

Dataset from A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study

2型糖尿病药物临床试验

非洲裔美国人糖尿病研究

Study of linagliptin vs. placebo in Black/African American patients with T2DM with a MTT sub-study

NIAID Data Ecosystem10

Dataset from A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 24 Weeks Treatment With Vildagliptin 100 mg qd or Metformin 1500 mg Daily in Elderly Drug Naive Patients With Type 2 Diabetes

2型糖尿病药物临床试验

老年患者疗效评估

This study is designed to demonstrate the efficacy and safety of vildagliptin compared to metformin in elderly drug naive patients with type 2 diabetes

NIAID Data Ecosystem00

Dataset from A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes

资源简介：

相关数据集